Applications of Trigonoliimines C in preparation of anti-fungal medicines for human bodies

An antifungal and drug technology, applied in the direction of antifungal agents, active ingredients of heterocyclic compounds, etc., can solve the problems of strong accumulation of toxicity, irritation, dizziness, allergies, etc. Effect

Inactive Publication Date: 2016-05-04
ZIBO DINGLI PATENT INFORMATION CONSULTING CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Pathogenic fungi seriously threaten human health and life. Antifungal drugs have been widely used as routine medications. Currently, clinically used antibacterial agents (such as ketoconazole, amikacin, gentamycin, vigorconazole, Itraconazole, terbinafine, amphotericin, fluconazole, etc.) have good curative effect on...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Applications of Trigonoliimines C in preparation of anti-fungal medicines for human bodies
  • Applications of Trigonoliimines C in preparation of anti-fungal medicines for human bodies
  • Applications of Trigonoliimines C in preparation of anti-fungal medicines for human bodies

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] Embodiment 1: the preparation of the compound TrigonoliiminesC tablet involved in the present invention:

[0015] Take 5 grams of compound Trigonoliimines C, add 195 grams of dextrin, mix well, and make 1000 tablets by conventional compression.

Embodiment 2

[0016] Embodiment 2: the preparation of the compound TrigonoliiminesC capsule involved in the present invention:

[0017] Get 5 grams of compound TrigonoliiminesC, add 195 grams of starch, mix evenly, and make 1000 capsules.

[0018] The following pharmacodynamic experiments will further illustrate its drug activity.

experiment example 1

[0019] Experimental example 1: Anti-fungal activity of TrigonoliiminesC

[0020] The anti-fungal activity experiment against human body adopts the method of concentration dilution, and each determination is repeated three times. The test pathogens include Trichomonas rubrum, Microsporum lanoides and Trichomonas clumps, and the concentration of bacteria solution is 105 / mL. The initial concentration of TrigonoliiminesC was 50.0 μg / mL (5% dimethyl sulfoxide DMSO), and it was serially diluted to 0.098 μg / mL. Equal volumes of bacteria liquid and test samples were mixed and cultured in a 96-well plate, and the culture temperature of human fungi was respectively 28°C, observe after 24 hours of incubation time, if no colonies are found, it is the lowest anti-human fungal concentration of the sample, that is, the MIC value. The positive control of this experiment is ketoconazole, and the results of TrigonoliiminesC against human fungi are shown in Table 1.

[0021] Table 1 Trigonoliim...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to applications of Trigonoliimines C in preparation of anti-fungal medicines for human bodies and belongs to the field of medicines. The Trigonoliimines C has strong functions of inhibiting trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, and therefore the Trigonoliimines C can be adopted as an anti-fungal compound for human bodies and is expected to be applied in preparation of related medicines.

Description

technical field [0001] The present invention relates to a new application of compound Trigonoliimines C, in particular to the application of Trigonoliimines C in the preparation of antifungal drugs for human body. Background technique [0002] Pathogenic fungi seriously threaten human health and life. Antifungal drugs have been widely used as routine medications. Currently, clinically used antibacterial agents (such as ketoconazole, amikacin, gentamycin, vigorconazole, Itraconazole, terbinafine, amphotericin, fluconazole, etc.) have good curative effect on skin and superficial infection, but these antibacterial drugs have strong cumulative toxicity, often causing liver and kidney damage, digestive tract Stimulation, dizziness, allergies, etc., so looking for new antifungal drugs with unique mechanism of action has become one of the hot spots in drug research and development today. [0003] The compound Trigonoliimines C involved in the present invention is a new compound pu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/55A61P31/10
CPCA61K31/55
Inventor 田丽华
Owner ZIBO DINGLI PATENT INFORMATION CONSULTING CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap